FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767555800> ?p ?o ?g. }

• W2767555800 endingPage "830" @default.
• W2767555800 startingPage "822" @default.
• W2767555800 abstract "The glucose-lowering effects of the glucagon-like peptide-1 receptor agonist, liraglutide, have been shown to rely on remaining β-cell function. However, the possible associations of remaining β-cell function with the glucose-lowering effects of liraglutide in combination with basal insulin remain unknown and warrant investigation.This was a single-center, retrospective, observational study carried out in a private hospital in Osaka, Japan. Type 2 diabetes patients who received a prescription change from insulin therapy, both multiple-dose insulin and basal insulin-supported oral therapy, to liraglutide and basal insulin combination and continued the therapy for 54 weeks without additional oral antidiabetic drugs or bolus insulin were retrospectively analyzed.Among the 72 participants who received a prescription change from multiple-dose insulin and basal insulin-supported oral therapy to liraglutide and basal insulin combination, 57 continued the therapy for 54 weeks. Of those who continued the therapy without receiving additional oral antidiabetic drugs or bolus insulin, seven participants achieved glycated hemoglobin < 7.0% at 54 weeks, but 30 participants did not. The participants who achieved glycated hemoglobin < 7.0% at 54 weeks had a significantly higher C-peptide immunoreactivity index, a β-cell function-related index frequently used in Japanese clinical settings. The receiver operating curve analysis showed that the C-peptide immunoreactivity index cut-off value for the achievement of glycated hemoglobin <7.0% at 54 weeks is 1.103.The current findings show that the glucose-lowering effects of liraglutide rely on remaining β-cell function, even when used with basal insulin; and suggest that liraglutide and basal insulin combination might require additional bolus insulin to fully compensate insulin insufficiency in individuals with reduced β-cell function." @default.
• W2767555800 created "2017-11-17" @default.
• W2767555800 creator A5002715434 @default.
• W2767555800 creator A5020304167 @default.
• W2767555800 creator A5033039645 @default.
• W2767555800 creator A5035250528 @default.
• W2767555800 creator A5052412166 @default.
• W2767555800 creator A5052679644 @default.
• W2767555800 creator A5067723444 @default.
• W2767555800 creator A5081800565 @default.
• W2767555800 creator A5082654550 @default.
• W2767555800 creator A5085783814 @default.
• W2767555800 date "2017-12-13" @default.
• W2767555800 modified "2023-10-05" @default.
• W2767555800 title "Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation" @default.
• W2767555800 cites W1557569792 @default.
• W2767555800 cites W1584571461 @default.
• W2767555800 cites W1606810773 @default.
• W2767555800 cites W1866428512 @default.
• W2767555800 cites W2002757015 @default.
• W2767555800 cites W2052754521 @default.
• W2767555800 cites W2063110816 @default.
• W2767555800 cites W2067533175 @default.
• W2767555800 cites W2104713027 @default.
• W2767555800 cites W2122413504 @default.
• W2767555800 cites W2122643907 @default.
• W2767555800 cites W2133406255 @default.
• W2767555800 cites W2150568560 @default.
• W2767555800 cites W2167296070 @default.
• W2767555800 cites W2193664952 @default.
• W2767555800 cites W23908558 @default.
• W2767555800 cites W2404914751 @default.
• W2767555800 cites W2548516204 @default.
• W2767555800 cites W2601745204 @default.
• W2767555800 cites W2752336761 @default.
• W2767555800 cites W2767555800 @default.
• W2767555800 cites W4237288256 @default.
• W2767555800 cites W4245063811 @default.
• W2767555800 cites W941973657 @default.
• W2767555800 doi "https://doi.org/10.1111/jdi.12773" @default.
• W2767555800 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6031501" @default.
• W2767555800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29106046" @default.
• W2767555800 hasPublicationYear "2017" @default.
• W2767555800 type Work @default.
• W2767555800 sameAs 2767555800 @default.
• W2767555800 citedByCount "19" @default.
• W2767555800 countsByYear W27675558002017 @default.
• W2767555800 countsByYear W27675558002018 @default.
• W2767555800 countsByYear W27675558002019 @default.
• W2767555800 countsByYear W27675558002020 @default.
• W2767555800 countsByYear W27675558002021 @default.
• W2767555800 countsByYear W27675558002022 @default.
• W2767555800 countsByYear W27675558002023 @default.
• W2767555800 crossrefType "journal-article" @default.
• W2767555800 hasAuthorship W2767555800A5002715434 @default.
• W2767555800 hasAuthorship W2767555800A5020304167 @default.
• W2767555800 hasAuthorship W2767555800A5033039645 @default.
• W2767555800 hasAuthorship W2767555800A5035250528 @default.
• W2767555800 hasAuthorship W2767555800A5052412166 @default.
• W2767555800 hasAuthorship W2767555800A5052679644 @default.
• W2767555800 hasAuthorship W2767555800A5067723444 @default.
• W2767555800 hasAuthorship W2767555800A5081800565 @default.
• W2767555800 hasAuthorship W2767555800A5082654550 @default.
• W2767555800 hasAuthorship W2767555800A5085783814 @default.
• W2767555800 hasBestOaLocation W27675558001 @default.
• W2767555800 hasConcept C126322002 @default.
• W2767555800 hasConcept C134018914 @default.
• W2767555800 hasConcept C2777180221 @default.
• W2767555800 hasConcept C2777538456 @default.
• W2767555800 hasConcept C2778024521 @default.
• W2767555800 hasConcept C2779306644 @default.
• W2767555800 hasConcept C2779920387 @default.
• W2767555800 hasConcept C2781308992 @default.
• W2767555800 hasConcept C555293320 @default.
• W2767555800 hasConcept C71924100 @default.
• W2767555800 hasConcept C90924648 @default.
• W2767555800 hasConceptScore W2767555800C126322002 @default.
• W2767555800 hasConceptScore W2767555800C134018914 @default.
• W2767555800 hasConceptScore W2767555800C2777180221 @default.
• W2767555800 hasConceptScore W2767555800C2777538456 @default.
• W2767555800 hasConceptScore W2767555800C2778024521 @default.
• W2767555800 hasConceptScore W2767555800C2779306644 @default.
• W2767555800 hasConceptScore W2767555800C2779920387 @default.
• W2767555800 hasConceptScore W2767555800C2781308992 @default.
• W2767555800 hasConceptScore W2767555800C555293320 @default.
• W2767555800 hasConceptScore W2767555800C71924100 @default.
• W2767555800 hasConceptScore W2767555800C90924648 @default.
• W2767555800 hasFunder F4320334764 @default.
• W2767555800 hasIssue "4" @default.
• W2767555800 hasLocation W27675558001 @default.
• W2767555800 hasLocation W27675558002 @default.
• W2767555800 hasLocation W27675558003 @default.
• W2767555800 hasLocation W27675558004 @default.
• W2767555800 hasLocation W27675558005 @default.
• W2767555800 hasOpenAccess W2767555800 @default.
• W2767555800 hasPrimaryLocation W27675558001 @default.
• W2767555800 hasRelatedWork W1964974772 @default.
• W2767555800 hasRelatedWork W1966225706 @default.

• next